BLRX

BioLineRX
BLRX

Overview Fund Trends Analyst Outlook Journalist POV

31 hedge funds and large institutions have $16.3M invested in BioLineRX in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
31
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$1.17M
2
+$92K
3
+$16K
4
CCB
Cutter & Co Brokerage
Missouri
+$10K
5
VF
Virtu Financial
New York
+$5K

Top Sellers

1
-$269K
2
-$33K
3
-$27K
4
Deutsche Bank
Deutsche Bank
Germany
-$26K
5
TSS
Two Sigma Securities
New York
-$25K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$4K
27
$4K
28
$3K
29
$2K
30
$1K
31
$1K
32
$86
33
–
34
–
35
–
36
–
37
–
1
2